246 related articles for article (PubMed ID: 18470479)
1. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.
Malito E; Hulse RE; Tang WJ
Cell Mol Life Sci; 2008 Aug; 65(16):2574-85. PubMed ID: 18470479
[TBL] [Abstract][Full Text] [Related]
2. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
Sikanyika NL; Parkington HC; Smith AI; Kuruppu S
Neurochem Res; 2019 Jun; 44(6):1289-1296. PubMed ID: 30806879
[TBL] [Abstract][Full Text] [Related]
3. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
[TBL] [Abstract][Full Text] [Related]
5. A highly sensitive peptide substrate for detecting two Aß-degrading enzymes: neprilysin and insulin-degrading enzyme.
Chen PT; Liao TY; Hu CJ; Wu ST; Wang SS; Chen RP
J Neurosci Methods; 2010 Jun; 190(1):57-62. PubMed ID: 20435063
[TBL] [Abstract][Full Text] [Related]
6. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
7. Peptidases, proteases and amyloid beta-peptide catabolism.
Hersh LB
Curr Pharm Des; 2003; 9(6):449-54. PubMed ID: 12570808
[TBL] [Abstract][Full Text] [Related]
8. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
Miners JS; Barua N; Kehoe PG; Gill S; Love S
J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
[TBL] [Abstract][Full Text] [Related]
9. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
10. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta degradation: a challenging task for brain peptidases.
Morelli L; Bulloj A; Leal MC; Castaño EM
Subcell Biochem; 2005; 38():129-45. PubMed ID: 15709476
[TBL] [Abstract][Full Text] [Related]
12. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
Carson JA; Turner AJ
J Neurochem; 2002 Apr; 81(1):1-8. PubMed ID: 12067222
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
15. The extracellular matrix enriched with membrane metalloendopeptidase and insulin-degrading enzyme suppresses the deposition of amyloid-beta peptide in Alzheimer's disease cell models.
Zhang S; Xiao T; Yu Y; Qiao Y; Xu Z; Geng J; Liang Y; Mei Y; Dong Q; Wang B; Wei J; Suo G
J Tissue Eng Regen Med; 2019 Oct; 13(10):1759-1769. PubMed ID: 31151136
[TBL] [Abstract][Full Text] [Related]
16. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes.
Liu Y; Guan H; Beckett TL; Juliano MA; Juliano L; Song ES; Chow KM; Murphy MP; Hersh LB
Peptides; 2007 Dec; 28(12):2348-55. PubMed ID: 17988763
[TBL] [Abstract][Full Text] [Related]
18. Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.
Shinohara M; Petersen RC; Dickson DW; Bu G
Acta Neuropathol; 2013 Apr; 125(4):535-47. PubMed ID: 23371365
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
20. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
Shen Y; Joachimiak A; Rosner MR; Tang WJ
Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
